Skip to main content
. 2023 Oct 13;10:1203427. doi: 10.3389/fcvm.2023.1203427

Table 5.

In-hospital clinical outcomes in the matched cohort (n = 186).

Controls N = 93 Cases N = 93 Difference (95% CI) p-value
Death 4 (4%) 14 (15%) −11% (−19%; −2%) 0.02
 Cardiovascular death 2 (2%) 3 (3%) −1% (−6%; 4%) 1.00
 Non-cardiovascular death 2 (2%) 10 (11%) −9% (−16%; −2%) 0.03
 Unclear death 0 (0%) 1 (1%) −1% (−3%; 1%) 1.00
Myocardial infarction 1 (1%) 2 (2%) −1% (−5%; 3%) 1.00
Unplanned revascularisation 0 (0%) 0 (0%)
Cerebrovascular event 0 (0%) 0 (0%)
 Stroke (ischemic or hemorrhagic) 0 (0%) 0 (0%)
Acute kidney injury 3 (3%) 6 (6%) −3% (−9%; 3%) 0.50
Major arrhythmia 9 (10%) 10 (11%) −1% (−10%; 8%) 1.00